Company news

Moberg Pharma AB news in 2026

Moberg Pharma AB's news releases, calls and decks from 2026, newest first.

View company

New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi

October 5, 2026

Moberg Pharma's Terclara[®](MOB-015) launched in Israel

September 23, 2026

Moberg Pharma strengthens organization ahead of European launch

August 11, 2026

New number of shares and votes in Moberg Pharma AB (publ)

June 30, 2026

Moberg Pharma reports progress on commercial launch preparations

June 15, 2026

Notice of Annual General Meeting in Moberg Pharma AB (publ)

April 17, 2026

Decks in 2026